Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Moderna Inc shares valued at $42,986 were sold by Mock James M on Oct 07 ’24. At $60.12 per share, Mock James M sold 715 shares. The insider’s holdings dropped to 9,505 shares worth approximately $0.48 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Klinger Shannon Thyme sold 551 shares, netting a total of over 40,539 in proceeds. Following the sale of shares at $73.57 each, the insider now holds 18,154 shares.
Before that, Klinger Shannon Thyme had added 551 shares to its account. In a trade valued at $40,539, the Officer bought Moderna Inc shares for $73.57 each.
As published in their initiating research note from Bernstein on October 17, 2024, Moderna Inc [MRNA] has been a Mkt perform and the price target has been revised to $55. Analysts at Oppenheimer downgraded the stock from ‘”an Outperform”‘ to ‘”a Perform”‘ outlook in a report released in mid September. As of September 13, 2024, JP Morgan has decreased its “Neutral” rating to a “an Underweight” for MRNA. Earlier on September 13, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for MRNA stock which previously was a “a Buy”.
Analyzing MRNA Stock Performance
During the last five days, there has been a drop of approximately -7.51%. Over the course of the year, Moderna Inc shares have dropped approximately -49.44%. Shares of the company reached a 52-week high of $170.47 on 05/24/24 and a 52-week low of $49.60 on 11/06/24. A 50-day SMA is recorded $62.46, while a 200-day SMA reached $99.37. Nevertheless, trading volume fell to 17.99 million shares from 10.68 million shares the previous day.
Support And Resistance Levels for Moderna Inc (MRNA)
According to the 24-hour chart, there is a support level at 47.91, which, if violated, would cause prices to drop to 45.55. In the upper region, resistance lies at 54.67. The next price resistance is at 59.06. RSI (Relative Strength Index) is 23.77 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.72, which suggests the price will decrease in the coming days. Percent R is at 91.59%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
